[ad_1] PARIS/WASHINGTON (Reuters) – France said on Thursday that the world’s nations would have equal access to any novel coronavirus vaccine developed by pharmaceuticals giant Sanofi (SASY.PA), a day after the CEO suggested that Americans

[ad_1] NEW YORK (Reuters) – The Federal Reserve’s pledged support for exchange-traded funds may not end up costing the central bank much, but will still have the desired effect of keeping the credit market afloat.

[ad_1] (Reuters) – Wall Street surged on Thursday as investors weighed the prospect of economic recovery against bellicose remarks from President Donald Trump regarding U.S.-China trade and a whistleblower’s dire warnings about the U.S. response

[ad_1] NEW YORK (Reuters) – Oil prices settled higher on Thursday after the International Energy Agency (IEA) forecast lower global stockpiles in the second half of 2020, although worries remain that a second surge in

[ad_1] WASHINGTON (Reuters) – The United States is considering measures it could take in response to Iran’s shipment of fuel to crisis-stricken Venezuela, a senior official in President Donald Trump’s administration told Reuters on Thursday.

[ad_1] NEW YORK (Reuters) – World stock markets fell for a third day on Thursday and safe-haven bonds rose as disappointing U.S. jobs data and signals by central banks that further government stimulus may be

[ad_1] WASHINGTON (Reuters) – U.S. President Donald Trump on Thursday said he was very disappointed in China over its failure to contain the novel coronavirus, saying the worldwide pandemic cast a pall over his trade

[ad_1] PARIS (Reuters) – Renault is preparing to substantially reduce its vehicle range, withdrawing well-known but ailing models like the Espace minivans, as part of looming cost cutting plans, four sources in the industry and

[ad_1] WASHINGTON (Reuters) – The novel coronavirus crisis continues to pummel the U.S. labor market, with the number of Americans filing for unemployment benefits falling less than expected last week, suggesting a second wave of

[ad_1] PARIS (Reuters) – France on Thursday said equal access to any coronavirus vaccine developed by Sanofi was non-negotiable and that no country such as the United States should have priority because of financial motivations.